📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas. (2024)

First Author: Deng J

Attributed to: The MUC1-ST/Siglec-9 innate check point axis in cancer: prevalence, prognostic significance and potential therapeutics. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s44321-024-00105-2

PubMed Identifier: 39103698

Publication URI: http://europepmc.org/abstract/MED/39103698

Type: Journal Article/Review

Volume: 16

Parent Publication: EMBO molecular medicine

Issue: 9

ISSN: 1757-4676